Protein kinase C-δ signaling regulates glucagon secretion from pancreatic islets

Autor: Natsumi Tokashiki, Motoyuki Tamaki, Kiyotake Yamamoto, Hiroyuki Mizuguchi, Youichi Sato, Hiroyuki Fukui, Aiko Yamauchi, Makoto Kobayashi
Rok vydání: 2017
Předmět:
0301 basic medicine
Male
medicine.medical_specialty
endocrine system
030209 endocrinology & metabolism
In Vitro Techniques
Glucagon
General Biochemistry
Genetics and Molecular Biology

Diabetes Mellitus
Experimental

03 medical and health sciences
chemistry.chemical_compound
Islets of Langerhans
Mice
0302 clinical medicine
Internal medicine
medicine
Animals
Humans
Phosphorylation
Protein kinase C
streptozotocin-induced diabetic mice
PKCδ
Pancreatic islets
pancreatic α-cells
Glucagon secretion
General Medicine
Mice
Inbred C57BL

Protein Kinase C-delta
030104 developmental biology
Endocrinology
medicine.anatomical_structure
chemistry
Phorbol
Disease Progression
glucagon secretion
Tetradecanoylphorbol Acetate
Quercetin
Signal transduction
Rottlerin
hormones
hormone substitutes
and hormone antagonists

Signal Transduction
Zdroj: The journal of medical investigation : JMI. 64(1.2)
ISSN: 1349-6867
Popis: Accumulating evidence supports the "glucagonocentric hypothesis", in which antecedent α-cell failure and inhibition of glucagon secretion are responsible for diabetes progression. Protein kinase C (PKC) is involved in glucagon secretion from α-cells, although which PKC isozyme is involved and the mechanism underlying this PKC-regulated glucagon secretion remains unknown. Here, the involvement of PKCδ in the onset and progression of diabetes was elucidated. Immunofluorescence studies revealed that PKCδ was expressed and activated in α-cells of STZ-induced diabetic model mice. Phorbol 12-myristate 13-acetate (PMA) stimulation significantly augmented glucagon secretion from isolated islets. Pre-treatment with quercetin and rottlerin, PKCδ signaling inhibitors, significantly suppressed the PMA-induced elevation of glucagon secretion. While Go6976, a Ca2+-dependent PKC selective inhibitor did not suppress glucagon secretion. Quercetin suppressed PMA-induced phosphorylation of Tyr311 of PKCδ in isolated islets. However, quercetin itself had no effect on either glucagon secretion or glucagon mRNA expression. Our data suggest that PKCδ signaling inhibitors suppressed glucagon secretion. Elucidation of detailed signaling pathways causing PKCδ activation in the onset and progression of diabetes followed by the augmentation of glucagon secretion could lead to the identification of novel therapeutic target molecules and the development of novel therapeutic drugs for diabetes. J. Med. Invest. 64: 122-128, February, 2017.
Databáze: OpenAIRE